Clinical Trial Update: GARDASIL™ Vaccine Impact in Population Study (V501-033)

View source ↗

Summary

Clinical trial update on GARDASIL vaccine impact in a population study (NCT01077856) completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Human Papillomavirus Infections

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Papillomavirus Infections | Status: COMPLETED | Results posted: 2015-12-10